Nursing home residents with Alzhiemer’s disease and related dementias, when not the majority of a facility population, may not be receiving the specialized care they need. In fact, only skilled nursing facilities that had a population with over 90% of residents with Alzheimer’s and other related dementias seemed to have better care. This is according […]
National Institutes of Health
A Phase 3 clinical trial of an antibody drug that enrolled residents and staff at skilled nursing and assisted living facilities found that the treatment significantly reduced the risk of contracting symptomatic COVID-19. The antibody drug, bamlanivimab (LY-CoV555), was developed by pharmaceutical giant Eli Lilly and Company (NYSE: LLY) for clinical use with the Vancouver-based […]
The number of Americans living with Alzheimer’s dementia or mild cognitive impairment will more than double in the coming years, according to a study from the University of California, Los Angeles (UCLA) Fielding School of Public Health. The latest figures highlight the need for intensive, nursing home-level care. In more granular terms, approximately 15 million […]